Patients No return to the status quo: Why now is the time for value-b... Value-based, person-centred healthcare is the key to system resilience – and now is the time to make it happen.
Partner Content Partner Content Identifying KOLs in Growing and Emerging Markets The process of discovering HCPs who are leading key opinion leaders (KOLs) in emerging and growing markets is not as straightforward as it is in other countries.
Partner Content Partner Content Social Health: The Future of Healthcare Marketing Inspire patients to make health decisions in new ways
Partner Content Partner Content Understanding Adherence: 5 Questions Patients Want to Be Ask... Various factors impact treatment plan adherence
Partner Content Partner Content Healthcare tech: the driving force behind value-based care? In 2020, healthcare technology investment went into overdrive.
Partner Content Partner Content PRISYM ID announces six further projects go live PRISYM ID has six new labeling software systems
News Gilead's twice-yearly PrEP drug is cleared by FDA Gilead has FDA approval for a twice-yearly PrEP drug, but could proposed cuts to US funding for HIV prevention programmes hinder its take-up?
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face